<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><description>让药物创造变得容易！我们致力于成为中国健康产业的传播者、服务者、推动者。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 17 Feb 2021 11:39:26 +0800</pubDate><image><url>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</url><title>药智网 | wechat-feeds</title><link>http://MzAxODA5MTU3NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>0到1000亿市值，他如何打造「口腔医疗帝国」</title><link>https://mp.weixin.qq.com/s/YVCIoY8rDPf9n5nxsM1IDw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VOBozXuCrfXAqYgGGBJmjBPK2y5z9vCuhBdyFSFYHMOEIKKYPDN02ElDHd5fRslfHqPeRYYJ1iaFZw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>换一种活法。]]></content:encoded><pubDate>Wed, 17 Feb 2021 10:09:32 +0800</pubDate></item><item><title>国内NDA阶段的2款自研3代EGFR-TKI，未来是否可期？</title><link>https://mp.weixin.qq.com/s/mc28j536cVePtXR5cGURLA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VOGibcdSlHMuJcVIKmXHnNhtjBhh9S8m06Pxtheiaz1Jl4C1h1jtMy9dFHia97TeEHmxmnIxBKrFzgAg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>艾森医药、上海艾力斯…]]></content:encoded><pubDate>Tue, 16 Feb 2021 11:09:48 +0800</pubDate></item><item><title>老鸟分享：CMO(首席医学官)是个啥职位？</title><link>https://mp.weixin.qq.com/s/_q1On3uvYWblYI_CbitCkA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VNR6Y7hItw2cpksibK5BMYaVj5icYUBuA37qb5vRXDgFSVUeibtlszN8FdWiand2VXVn7c3mgpWiaLWEaw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>如何成为称职的CMO？]]></content:encoded><pubDate>Mon, 15 Feb 2021 09:57:28 +0800</pubDate></item><item><title>百亿HER2单抗市场，曲妥珠单抗生物类似药是否能迎来春天？</title><link>https://mp.weixin.qq.com/s/nZrrDiIWQTiNPvTRKjmoTA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VOBozXuCrfXAqYgGGBJmjBPtFwwoVdqdTP9icZIfia8acdqPnTEnllgqcTza8RTIWDicb2EnTa7WBG4A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>国内共有7个曲妥珠单抗的生物类似药处于III期临床。]]></content:encoded><pubDate>Sun, 14 Feb 2021 10:06:11 +0800</pubDate></item><item><title>JAK-STAT发现30年：8款产品已上市，国内赛道恒瑞、信达…已布局</title><link>https://mp.weixin.qq.com/s/BwkSPO3Q3_NYZtoXEmnJnA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VNR6Y7hItw2cpksibK5BMYaVTdwpKTYa0kiaaPibSvISiapu18aIn3BDmtSvZxgk4z7BQQn78SCDVc9tg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>市场机遇与挑战并存。]]></content:encoded><pubDate>Sat, 13 Feb 2021 10:27:07 +0800</pubDate></item><item><title>大年初一 ，开门迎喜 ，药智网携全体员工给您拜年啦~祝大家牛转钱坤，大吉大利！</title><link>https://mp.weixin.qq.com/s/RTUvavVtH9eSycVsYbVK2A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VOGibcdSlHMuJcVIKmXHnNhtHe5PzYFXZjFnA9Mz3jz7jyjEARSjyzvVlpcRxbNX8JBSEbbAo0dWEg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>大年初一 ，开门迎喜 ，药智网携全体员工给您拜年啦~祝大家牛转钱坤，大吉大利！]]></content:encoded><pubDate>Fri, 12 Feb 2021 00:00:29 +0800</pubDate></item><item><title>分享图片</title><link>https://mp.weixin.qq.com/s/uJiSolDrgpLfnt_Q9wp-3Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VOGibcdSlHMuJcVIKmXHnNhtLWGNztuHVPSnEf7ol6lhQc4HicO1knphSrvOQm6jkg8I6q7McDHOFFw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Thu, 11 Feb 2021 08:12:52 +0800</pubDate></item><item><title>深度长文：生物制剂管线全解析！</title><link>https://mp.weixin.qq.com/s/krdhmVFJnMcl5Cl_dg7AEQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VPSfvbmIV5cNlIZWFbBOibqdq7aHraxzBReKaNqOTDadFBib5Y2cGUdbgUD3KeGZCkqrrXaTsYFlMQg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>窥探2021年生物制剂发展趋势！]]></content:encoded><pubDate>Wed, 10 Feb 2021 09:51:11 +0800</pubDate></item><item><title>2020年CRO平均净利润行业第一，业绩下降的仅三家，最高跌幅达968%</title><link>https://mp.weixin.qq.com/s/4eaSVQ9EQLUKc8fNp2DEXQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VNR6Y7hItw2cpksibK5BMYaV8YxlQibYfdtibiamtdrx2eicCcp4ibecsSTTd9ficVw2fBtEk3GOYLY4QUKg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药行业平均净利润2.81亿，CRO行业业绩远高于平均水平。]]></content:encoded><pubDate>Tue, 09 Feb 2021 10:24:57 +0800</pubDate></item><item><title>2020诺华净销售额487亿美元！创新成果突显，80%销售额来自创新药</title><link>https://mp.weixin.qq.com/s/ECehlxvKu68JoTvDGCYeLA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/SmibgqHu83VPSfvbmIV5cNlIZWFbBOibqdyrgqXqkgg8WwYMr8BdAkyVvw0vcHMI8WiaAOjdf1O3w2soUWibAxJEzA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>7款新药及适应症获批，2项突破性疗法被认定。]]></content:encoded><pubDate>Mon, 08 Feb 2021 10:07:20 +0800</pubDate></item></channel></rss>